Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 74

Related Citations for PubMed (Select 22969947)

1.

Association between IL6 -174G/C and cancer: A meta-analysis of 105,482 individuals.

Liu RY, Song X, Chen P, Lei Z, Miao J, Yi N, Zhang K, Pasche B, Zhang HT.

Exp Ther Med. 2012 Apr;3(4):655-664. Epub 2012 Jan 13.

2.

IL-6 -174G>C polymorphism and cancer risk: a meta-analysis involving 29,377 cases and 37,739 controls.

Xu B, Niu XB, Wang ZD, Cheng W, Tong N, Mi YY, Min ZC, Tao J, Li PC, Zhang W, Wu HF, Zhang ZD, Wang ZJ, Hua LX, Feng NH, Wang XR.

Mol Biol Rep. 2011 Apr;38(4):2589-96. doi: 10.1007/s11033-010-0399-1. Epub 2010 Nov 23.

PMID:
21104146
3.

Influence of interleukin-6 gene -174G>C polymorphism on development of atherosclerosis: a meta-analysis of 50 studies involving 33,514 subjects.

Yin YW, Li JC, Zhang M, Wang JZ, Li BH, Liu Y, Liao SQ, Zhang MJ, Gao CY, Zhang LL.

Gene. 2013 Oct 15;529(1):94-103. doi: 10.1016/j.gene.2013.07.074. Epub 2013 Aug 14. Erratum in: Gene. 2014 Jan 25;534(2):456.

PMID:
23954871
4.

Lack of association between -174G>C and -634C>G polymorphisms in interleukin-6 promoter region and lung cancer risk: a meta-analysis.

Jiao F, Xu D, Li Q, Liu G, Liu H, Ren T.

Tumour Biol. 2014 May;35(5):5021-7. doi: 10.1007/s13277-014-1662-1. Epub 2014 Feb 4.

PMID:
24492940
5.

Interleukin-6 -174G/C polymorphism and the risk of Alzheimer's disease in Caucasians: a meta-analysis.

Han XM, Wang CH, Sima X, Liu SY.

Neurosci Lett. 2011 Oct 17;504(1):4-8. doi: 10.1016/j.neulet.2011.06.055. Epub 2011 Jul 13.

PMID:
21767605
6.

Interleukin 6-174G>C polymorphism and risk of aneurysmal subarachnoid hemorrhage: case-control study and meta-analysis.

Pera J, Dziedzic T, Adamski M, Jagiella J, Krupa M, Moskala M, Szczudlik A, Slowik A.

Acta Neurol Scand. 2012 Feb;125(2):111-5. doi: 10.1111/j.1600-0404.2011.01505.x. Epub 2011 Mar 16.

PMID:
21410438
7.

Lack of association between the interleukin 6 gene -174G>C polymorphism and colorectal cancer: evidence from a meta-analysis.

Hu JJ, Wang ZT, Zhong J.

Genet Mol Res. 2013 Jul 8;12(3):2205-14. doi: 10.4238/2013.July.8.2.

8.

Lack of an association between a functional polymorphism in the interleukin-6 gene promoter and breast cancer risk: a meta-analysis involving 25,703 subjects.

Yu KD, Di GH, Fan L, Chen AX, Yang C, Shao ZM.

Breast Cancer Res Treat. 2010 Jul;122(2):483-8. doi: 10.1007/s10549-009-0706-5. Epub 2009 Dec 31. Review.

PMID:
20043205
9.

[Polymorphic variants of genes encoding interleukin-6 and fibrinogen, the risk of ischemic stroke and fibrinogen levels].

Titov BV, Barsova RM, Martynov MIu, Nikonova AA, Favorov AV, Gusev EI, Favorova OO.

Mol Biol (Mosk). 2012 Jan-Feb;46(1):93-102. Russian.

PMID:
22642105
10.

IL6-174G/C polymorphism and fracture risk.

Zhang Z, He N, Zhang T.

Int J Clin Exp Med. 2014 Oct 15;7(10):3795-9. eCollection 2014.

11.

Association of a LSP1 gene rs3817198T>C polymorphism with breast cancer risk: evidence from 33,920 cases and 35,671 controls.

Chen MB, Li C, Shen WX, Guo YJ, Shen W, Lu PH.

Mol Biol Rep. 2011 Oct;38(7):4687-95. doi: 10.1007/s11033-010-0603-3. Epub 2010 Dec 2.

PMID:
21127985
12.

Polymorphisms of -174G>C and -572G>C in the interleukin 6 (IL-6) gene and coronary heart disease risk: a meta-analysis of 27 research studies.

Zheng GH, Chen HY, Xiong SQ.

PLoS One. 2012;7(4):e34839. doi: 10.1371/journal.pone.0034839. Epub 2012 Apr 11.

13.

Association between interleukin-6 -174G/C polymorphism and the risk of Alzheimer's disease: a meta-analysis.

Hua Y, Guo X, Huang Q, Kong Y, Lu X.

Int J Neurosci. 2013 Sep;123(9):626-35. doi: 10.3109/00207454.2013.784286. Epub 2013 Apr 23.

PMID:
23510010
14.

Interleukin 1 beta (IL1B) promoter polymorphism and cancer risk: evidence from 47 published studies.

He B, Zhang Y, Pan Y, Xu Y, Gu L, Chen L, Wang S.

Mutagenesis. 2011 Sep;26(5):637-42. doi: 10.1093/mutage/ger025. Epub 2011 Jun 7.

15.

Association between IL-6-174G/C polymorphism and risk of multiple sclerosis: a meta-analysis.

Hu S, Chen Y, Sun XD, Li FJ, Shu QF, Liu XL, Jiang SF.

Genet Test Mol Biomarkers. 2014 Feb;18(2):127-30. doi: 10.1089/gtmb.2013.0387. Epub 2013 Dec 11. Review.

PMID:
24328460
16.

Apolipoprotein A5 gene promoter region-1131T/C polymorphism is associated with risk of ischemic stroke and elevated triglyceride levels: a meta-analysis.

Pi Y, Zhang L, Yang Q, Li B, Guo L, Fang C, Gao C, Wang J, Xiang J, Li J.

Cerebrovasc Dis. 2012;33(6):558-65. doi: 10.1159/000338781. Epub 2012 Jun 8.

PMID:
22688093
17.

Association between the hMSH2 IVS12-6 T>C polymorphism and cancer risk: A meta-analysis.

Wu S, Chen J, Ji Y, Liu Y, Gao L, Chen G, Shen K, Huang B.

Exp Ther Med. 2011 Nov;2(6):1193-1198. Epub 2011 Aug 16.

18.

Lack of association between hOGG1 Ser326Cys polymorphism and the risk of bladder cancer: a meta-analysis.

Li D, Liu H, Yan L, Tang Y, Ren J, Xu Z.

Urol Int. 2012;88(1):88-94. doi: 10.1159/000331931. Epub 2011 Dec 9.

PMID:
22156293
19.

Lack of an association between interleukin-6 gene promoter polymorphisms (-174G/C, -572G/C) and ischemic heart disease and/or ischemic stroke: a meta-analysis.

Ma Y, Tang RK, Yang X, Peng GG, Liu Y, Wang XM, Wu BH, Yu JM.

Hum Immunol. 2011 Aug;72(8):641-51. doi: 10.1016/j.humimm.2011.03.019. Epub 2011 Apr 14.

PMID:
21536090
20.

CYP17 T27C polymorphism and prostate cancer risk: a meta-analysis based on 31 studies.

Wei B, Zhang Y, Xi B, Chang J, Bai J, Su J.

J Biomed Res. 2010 May;24(3):233-41. doi: 10.1016/S1674-8301(10)60033-4.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk